Selected research
Market Structure
Global Plasmid DNA CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Plasmid DNA CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Plasmid DNA CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plasmid DNA CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plasmid DNA CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Plasmid DNA CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Plasmid DNA CDMO Service include Creative Biogene, AGC Biologics, Biovian, GenScript ProBio, Charles River Laboratories, PackGene, Catalent Biologics, Patheon and Mycenax Biotech Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Plasmid DNA CDMO Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plasmid DNA CDMO Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plasmid DNA CDMO Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Plasmid DNA CDMO Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Plasmid DNA CDMO Service Segment by Company
Creative Biogene
AGC Biologics
Biovian
GenScript ProBio
Charles River Laboratories
PackGene
Catalent Biologics
Patheon
Mycenax Biotech Inc
VGXI
Esco Aster
Eurogentec
53Biologics
SK pharmteco
Cytovance Biologics
Aldevron
Bionova Scientific
Plasmid DNA CDMO Service Segment by Type
Research Grade
Commercial Grade
GMP Grade
Others
Plasmid DNA CDMO Service Segment by Application
Preclinical
Clinical
Commercial
Plasmid DNA CDMO Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasmid DNA CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasmid DNA CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasmid DNA CDMO Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Plasmid DNA CDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Plasmid DNA CDMO Service industry.
Chapter 3: Detailed analysis of Plasmid DNA CDMO Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasmid DNA CDMO Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Research Grade
- Commercial Grade
- GMP Grade
- Others
Applications
- Preclinical
- Clinical
- Commercial
Companies covered
- Creative Biogene
- AGC Biologics
- Biovian
- GenScript ProBio
- Charles River Laboratories
- PackGene
- Catalent Biologics
- Patheon
- Mycenax Biotech Inc
- VGXI
- Esco Aster
- Eurogentec
- 53Biologics
- SK pharmteco
- Cytovance Biologics
- Aldevron
- Bionova Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Plasmid DNA CDMO Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Research Grade
- 1.2.3 Commercial Grade
- 1.2.4 GMP Grade
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Plasmid DNA CDMO Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Preclinical
- 1.3.3 Clinical
- 1.3.4 Commercial
- 1.4 Global Market Growth Prospects
- 1.5 Global Plasmid DNA CDMO Service Growth Trends by Region
- 1.5.1 Global Plasmid DNA CDMO Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Plasmid DNA CDMO Service Market Size by Region (2021-2026)
- 1.5.3 Plasmid DNA CDMO Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Plasmid DNA CDMO Service Market Dynamics
- 2.1 Plasmid DNA CDMO Service Industry Trends
- 2.2 Plasmid DNA CDMO Service Industry Drivers
- 2.3 Plasmid DNA CDMO Service Industry Opportunities and Challenges
- 2.4 Plasmid DNA CDMO Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Plasmid DNA CDMO Service Revenue by Company (2021-2026)
- 3.2 Global Plasmid DNA CDMO Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Plasmid DNA CDMO Service Key Company Head office and Area Served
- 3.4 Global Plasmid DNA CDMO Service Company, Product Type & Application
- 3.5 Global Plasmid DNA CDMO Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Plasmid DNA CDMO Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Plasmid DNA CDMO Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Plasmid DNA CDMO Service Tier 1, Tier 2, and Tier 3
4 Plasmid DNA CDMO Service Market by Type
- 4.1 Global Plasmid DNA CDMO Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Plasmid DNA CDMO Service Market Size by Type (2021-2032)
- 4.3 Global Plasmid DNA CDMO Service Market Size Share by Type (2021-2032)
5 Plasmid DNA CDMO Service Market by Application
- 5.1 Global Plasmid DNA CDMO Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Plasmid DNA CDMO Service Market Size by Application (2021-2032)
- 5.3 Global Plasmid DNA CDMO Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Creative Biogene
- 6.1.1 Creative Biogene Company Information
- 6.1.2 Creative Biogene Business Overview
- 6.1.3 Creative Biogene Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Creative Biogene Plasmid DNA CDMO Service Product Portfolio
- 6.1.5 Creative Biogene Recent Developments
- 6.2 AGC Biologics
- 6.2.1 AGC Biologics Company Information
- 6.2.2 AGC Biologics Business Overview
- 6.2.3 AGC Biologics Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 AGC Biologics Plasmid DNA CDMO Service Product Portfolio
- 6.2.5 AGC Biologics Recent Developments
- 6.3 Biovian
- 6.3.1 Biovian Company Information
- 6.3.2 Biovian Business Overview
- 6.3.3 Biovian Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Biovian Plasmid DNA CDMO Service Product Portfolio
- 6.3.5 Biovian Recent Developments
- 6.4 GenScript ProBio
- 6.4.1 GenScript ProBio Company Information
- 6.4.2 GenScript ProBio Business Overview
- 6.4.3 GenScript ProBio Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 GenScript ProBio Plasmid DNA CDMO Service Product Portfolio
- 6.4.5 GenScript ProBio Recent Developments
- 6.5 Charles River Laboratories
- 6.5.1 Charles River Laboratories Company Information
- 6.5.2 Charles River Laboratories Business Overview
- 6.5.3 Charles River Laboratories Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Charles River Laboratories Plasmid DNA CDMO Service Product Portfolio
- 6.5.5 Charles River Laboratories Recent Developments
- 6.6 PackGene
- 6.6.1 PackGene Company Information
- 6.6.2 PackGene Business Overview
- 6.6.3 PackGene Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 PackGene Plasmid DNA CDMO Service Product Portfolio
- 6.6.5 PackGene Recent Developments
- 6.7 Catalent Biologics
- 6.7.1 Catalent Biologics Company Information
- 6.7.2 Catalent Biologics Business Overview
- 6.7.3 Catalent Biologics Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Catalent Biologics Plasmid DNA CDMO Service Product Portfolio
- 6.7.5 Catalent Biologics Recent Developments
- 6.8 Patheon
- 6.8.1 Patheon Company Information
- 6.8.2 Patheon Business Overview
- 6.8.3 Patheon Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Patheon Plasmid DNA CDMO Service Product Portfolio
- 6.8.5 Patheon Recent Developments
- 6.9 Mycenax Biotech Inc
- 6.9.1 Mycenax Biotech Inc Company Information
- 6.9.2 Mycenax Biotech Inc Business Overview
- 6.9.3 Mycenax Biotech Inc Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Mycenax Biotech Inc Plasmid DNA CDMO Service Product Portfolio
- 6.9.5 Mycenax Biotech Inc Recent Developments
- 6.10 VGXI
- 6.10.1 VGXI Company Information
- 6.10.2 VGXI Business Overview
- 6.10.3 VGXI Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 VGXI Plasmid DNA CDMO Service Product Portfolio
- 6.10.5 VGXI Recent Developments
- 6.11 Esco Aster
- 6.11.1 Esco Aster Company Information
- 6.11.2 Esco Aster Business Overview
- 6.11.3 Esco Aster Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Esco Aster Plasmid DNA CDMO Service Product Portfolio
- 6.11.5 Esco Aster Recent Developments
- 6.12 Eurogentec
- 6.12.1 Eurogentec Company Information
- 6.12.2 Eurogentec Business Overview
- 6.12.3 Eurogentec Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Eurogentec Plasmid DNA CDMO Service Product Portfolio
- 6.12.5 Eurogentec Recent Developments
- 6.13 53Biologics
- 6.13.1 53Biologics Company Information
- 6.13.2 53Biologics Business Overview
- 6.13.3 53Biologics Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 53Biologics Plasmid DNA CDMO Service Product Portfolio
- 6.13.5 53Biologics Recent Developments
- 6.14 SK pharmteco
- 6.14.1 SK pharmteco Company Information
- 6.14.2 SK pharmteco Business Overview
- 6.14.3 SK pharmteco Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 SK pharmteco Plasmid DNA CDMO Service Product Portfolio
- 6.14.5 SK pharmteco Recent Developments
- 6.15 Cytovance Biologics
- 6.15.1 Cytovance Biologics Company Information
- 6.15.2 Cytovance Biologics Business Overview
- 6.15.3 Cytovance Biologics Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Cytovance Biologics Plasmid DNA CDMO Service Product Portfolio
- 6.15.5 Cytovance Biologics Recent Developments
- 6.16 Aldevron
- 6.16.1 Aldevron Company Information
- 6.16.2 Aldevron Business Overview
- 6.16.3 Aldevron Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Aldevron Plasmid DNA CDMO Service Product Portfolio
- 6.16.5 Aldevron Recent Developments
- 6.17 Bionova Scientific
- 6.17.1 Bionova Scientific Company Information
- 6.17.2 Bionova Scientific Business Overview
- 6.17.3 Bionova Scientific Plasmid DNA CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Bionova Scientific Plasmid DNA CDMO Service Product Portfolio
- 6.17.5 Bionova Scientific Recent Developments
7 North America
- 7.1 North America Plasmid DNA CDMO Service Market Size (2021-2032)
- 7.2 North America Plasmid DNA CDMO Service Market Size by Type
- 7.2.1 North America Plasmid DNA CDMO Service Market Size by Type (2021-2026)
- 7.2.2 North America Plasmid DNA CDMO Service Market Size by Type (2027-2032)
- 7.2.3 North America Plasmid DNA CDMO Service Market Share by Type (2021-2032)
- 7.3 North America Plasmid DNA CDMO Service Market Size by Application
- 7.3.1 North America Plasmid DNA CDMO Service Market Size by Application (2021-2026)
- 7.3.2 North America Plasmid DNA CDMO Service Market Size by Application (2027-2032)
- 7.3.3 North America Plasmid DNA CDMO Service Market Share by Application (2021-2032)
- 7.4 North America Plasmid DNA CDMO Service Market Size by Country
- 7.4.1 North America Plasmid DNA CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Plasmid DNA CDMO Service Market Size by Country (2021-2026)
- 7.4.3 North America Plasmid DNA CDMO Service Market Size by Country (2027-2032)
- 7.4.4 North America Plasmid DNA CDMO Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Plasmid DNA CDMO Service Market Size (2021-2032)
- 8.2 Europe Plasmid DNA CDMO Service Market Size by Type
- 8.2.1 Europe Plasmid DNA CDMO Service Market Size by Type (2021-2026)
- 8.2.2 Europe Plasmid DNA CDMO Service Market Size by Type (2027-2032)
- 8.2.3 Europe Plasmid DNA CDMO Service Market Share by Type (2021-2032)
- 8.3 Europe Plasmid DNA CDMO Service Market Size by Application
- 8.3.1 Europe Plasmid DNA CDMO Service Market Size by Application (2021-2026)
- 8.3.2 Europe Plasmid DNA CDMO Service Market Size by Application (2027-2032)
- 8.3.3 Europe Plasmid DNA CDMO Service Market Share by Application (2021-2032)
- 8.4 Europe Plasmid DNA CDMO Service Market Size by Country
- 8.4.1 Europe Plasmid DNA CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Plasmid DNA CDMO Service Market Size by Country (2021-2026)
- 8.4.3 Europe Plasmid DNA CDMO Service Market Size by Country (2027-2032)
- 8.4.4 Europe Plasmid DNA CDMO Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Plasmid DNA CDMO Service Market Size (2021-2032)
- 9.2 China Plasmid DNA CDMO Service Market Size by Type
- 9.2.1 China Plasmid DNA CDMO Service Market Size by Type (2021-2026)
- 9.2.2 China Plasmid DNA CDMO Service Market Size by Type (2027-2032)
- 9.2.3 China Plasmid DNA CDMO Service Market Share by Type (2021-2032)
- 9.3 China Plasmid DNA CDMO Service Market Size by Application
- 9.3.1 China Plasmid DNA CDMO Service Market Size by Application (2021-2026)
- 9.3.2 China Plasmid DNA CDMO Service Market Size by Application (2027-2032)
- 9.3.3 China Plasmid DNA CDMO Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Plasmid DNA CDMO Service Market Size (2021-2032)
- 10.2 Asia Plasmid DNA CDMO Service Market Size by Type
- 10.2.1 Asia Plasmid DNA CDMO Service Market Size by Type (2021-2026)
- 10.2.2 Asia Plasmid DNA CDMO Service Market Size by Type (2027-2032)
- 10.2.3 Asia Plasmid DNA CDMO Service Market Share by Type (2021-2032)
- 10.3 Asia Plasmid DNA CDMO Service Market Size by Application
- 10.3.1 Asia Plasmid DNA CDMO Service Market Size by Application (2021-2026)
- 10.3.2 Asia Plasmid DNA CDMO Service Market Size by Application (2027-2032)
- 10.3.3 Asia Plasmid DNA CDMO Service Market Share by Application (2021-2032)
- 10.4 Asia Plasmid DNA CDMO Service Market Size by Country
- 10.4.1 Asia Plasmid DNA CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Plasmid DNA CDMO Service Market Size by Country (2021-2026)
- 10.4.3 Asia Plasmid DNA CDMO Service Market Size by Country (2027-2032)
- 10.4.4 Asia Plasmid DNA CDMO Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Plasmid DNA CDMO Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Plasmid DNA CDMO Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Plasmid DNA CDMO Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Plasmid DNA CDMO Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst